The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Kobel, Bryan Leland
    Executive born in December 1979
    Individual (2 offsprings)
    Officer
    2021-10-15 ~ now
    OF - director → CIF 0
  • 2
    Thorp, Martin
    Chief Financial Officer born in March 1952
    Individual (17 offsprings)
    Officer
    2016-03-04 ~ now
    OF - director → CIF 0
  • 3
    TC BIOPHARM (HOLDINGS) LIMITED - 2022-01-10
    TCB NEWCO 2 LIMITED - 2021-11-01
    Maxim 1, 2 Parklands Way, Holytown, Motherwell, Scotland
    Corporate (5 parents, 1 offspring)
    Person with significant control
    2021-12-17 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
Ceased 14
  • 1
    Takeda, Kazuyuki
    Company Director born in June 1963
    Individual
    Officer
    2016-09-23 ~ 2019-10-01
    OF - director → CIF 0
  • 2
    Suzuki, Kunihiko
    Business Executive born in May 1959
    Individual
    Officer
    2013-07-23 ~ 2016-09-23
    OF - director → CIF 0
  • 3
    Clark, Alan George
    Company Director born in January 1972
    Individual (2 offsprings)
    Officer
    2016-07-22 ~ 2021-10-15
    OF - director → CIF 0
  • 4
    Scott, Angela Rita Rafaella
    Chief Operating Officer born in August 1963
    Individual (1 offspring)
    Officer
    2018-12-19 ~ 2023-04-23
    OF - director → CIF 0
  • 5
    Haas, Athol Peter
    Company Director born in December 1975
    Individual (11 offsprings)
    Officer
    2014-03-24 ~ 2016-09-23
    OF - director → CIF 0
  • 6
    Leek, Michael David, Dr
    Chief Executive born in February 1960
    Individual (3 offsprings)
    Officer
    2013-07-01 ~ 2023-04-21
    OF - director → CIF 0
  • 7
    Rintoul, Toby
    Individual
    Officer
    2018-08-03 ~ 2022-09-28
    OF - secretary → CIF 0
  • 8
    Moussavi, Artin
    Company Director born in August 1972
    Individual (3 offsprings)
    Officer
    2014-03-04 ~ 2018-01-01
    OF - director → CIF 0
  • 9
    Porter, Lorraine Christie
    Director born in February 1960
    Individual (1 offspring)
    Officer
    2015-07-06 ~ 2021-10-20
    OF - director → CIF 0
  • 10
    Minoura, Kimihito
    Managing Director born in October 1972
    Individual
    Officer
    2019-10-01 ~ 2021-10-20
    OF - director → CIF 0
  • 11
    Miyamoto, Hajime
    Company Director born in April 1958
    Individual
    Officer
    2014-12-09 ~ 2018-12-14
    OF - director → CIF 0
  • 12
    Gallagher, David Ewart
    Individual
    Officer
    2014-03-24 ~ 2018-08-03
    OF - secretary → CIF 0
  • 13
    Maekawa, Ryuji
    Company Director born in August 1958
    Individual
    Officer
    2014-03-24 ~ 2014-12-08
    OF - director → CIF 0
  • 14
    2-3-12, Shin-yokohama, Kohoku-ku, Yokohama, Japan
    Corporate
    Person with significant control
    2016-04-06 ~ 2016-09-21
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
parent relation
Company in focus

TC BIOPHARM LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Tangible fixed assets
672,004 GBP2016-07-31
532,634 GBP2015-07-31
Debtors
195,759 GBP2016-07-31
104,514 GBP2015-07-31
Cash at bank and in hand
596 GBP2016-07-31
640,970 GBP2015-07-31
Current Assets
196,355 GBP2016-07-31
745,484 GBP2015-07-31
Current liabilities
-584,526 GBP2016-07-31
-363,019 GBP2015-07-31
Net Current Assets/Liabilities
-388,171 GBP2016-07-31
382,465 GBP2015-07-31
Total Assets Less Current Liabilities
283,833 GBP2016-07-31
915,099 GBP2015-07-31
Non-current liabilities
-17,741 GBP2016-07-31
-329,853 GBP2015-07-31
Accruals and deferred income
-66,000 GBP2016-07-31
-77,000 GBP2015-07-31
Called-up share capital
1,293,388 GBP2016-07-31
981,522 GBP2015-07-31
Share premium account
2,214,551 GBP2016-07-31
694,004 GBP2015-07-31
Retained earnings
-3,307,847 GBP2016-07-31
-1,167,280 GBP2015-07-31
Shareholder's fund
200,092 GBP2016-07-31
508,246 GBP2015-07-31
Number of shares allotted
Class 1 ordinary share
1,293,388 shares2016-07-31
Par Value of Share
Class 1 ordinary share
1 GBP2015-08-01 ~ 2016-07-31
Paid-up share capital
Class 1 ordinary share
1,293,388 GBP2016-07-31
981,522 GBP2015-07-31
  • TC BIOPHARM LIMITED
    Info
    Registered number SC453579
    Maxim 1 2 Parklands Way, Holytown, Motherwell, Lanarkshire ML1 4WR
    Private Limited Company incorporated on 2013-07-01 (11 years 11 months). The company status is Active.
    The last date of confirmation statement was made at 2024-07-01
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.